Skip to main content
OpenTrials

Clinical trial condition

Keratosis

Explore clinical trials studying Keratosis. Study availability and eligibility vary by location and protocol.

416 public trials 37 recruiting studies
Refine in advanced search Browse all conditions

Keratosis trial results

Completed

A Multicenter Study to Evaluate the Safety and Efficacy of PEP005 Topical Gel When Used to Treat Actinic Keratoses on the Head (Face or Scalp)

NCT00700063

Conditions
Actinic Keratosis, Keratosis, Keratosis, Actinic, +4 more
Locations
  • Burke Pharmaceutical Research Hot Springs, Arizona, United States
  • Dermatology Research of Arkansas Little Rock, Arkansas, United States
  • Koppel Dermatology Los Angeles, California, United States
  • Dermatology Research Associates Los Angeles, California, United States
View all 28 locations
View Trial Details
Completed

A Multi-center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp)

NCT00916006

Conditions
Actinic Keratosis, Keratosis, Keratosis, Actinic, +4 more
Locations
  • Dermatology Research Associates Los Angeles, California, United States
  • Dermatology Specialists Inc Oceanside, California, United States
  • Skin Surgery Medical Group Inc. San Diego, California, United States
  • Conant Medical Group San Francisco, California, United States
View all 21 locations
View Trial Details
Completed

A Study to Examine the Safety and Toleration of PEP005 Topical Gel in Patients With Actinic Keratoses on the Top of the Hand

NCT00544297

Conditions
Actinic Keratosis, Keratosis, Keratosis, Actinic, +4 more
Locations
  • Skin Surgery Medical Group Inc San Diego, California, United States
  • Gwinnett Clinical Research Centre Snellville, Georgia, United States
  • Dermatology Clinical Research Centre of San Antonio San Antonio, Texas, United States
  • Dermatology Associates of Tyler Tyler, Texas, United States
View Trial Details
Completed

A Long Term Follow up Study of Patients Who Have Complete Clearance of Their Actinic Keratosis (AK) Lesions at the Day 57 Visit in the PEP005-028 Study

NCT00989313

Conditions
Actinic Keratosis, Keratosis, Keratosis, Actinic, +4 more
Locations
  • Burke Pharmaceutical Research Hot Springs, Arizona, United States
  • Skin Surgery Medical Group Inc. San Diego, California, United States
  • Atlanta Dermatology, Vein & Research Center, LLC Alpharetta, Georgia, United States
  • Altman Dermatology Associates Arlington Heights, Illinois, United States
View all 17 locations
View Trial Details
Completed

A Long Term Follow up Study of Patients Who Have Completed the PEP005-020 Study

NCT00952783

Conditions
Actinic Keratosis, Keratosis, Keratosis, Actinic, +4 more
Locations
  • Park Avenue Dermatology Orange Park, Florida, United States
  • Medaphase Inc Newnan, Georgia, United States
  • Gwinnett Clinical Research Centre Snellville, Georgia, United States
  • Michigan Center for Research Corp Clinton Twp, Michigan, United States
View Trial Details
Completed

A Long Term Follow up Study of Patients Who Have Completed the PEP005-016 or PEP005-025 Studies

NCT00953732

Conditions
Actinic Keratosis, Keratosis, Keratosis, Actinic, +4 more
Locations
  • Burke Pharmaceutical Research Hot Springs, Arizona, United States
  • Center for Dermatology Fremont, California, United States
  • Dermatology Research Associates Los Angeles, California, United States
  • Dermatology Specialists Inc Oceanside, California, United States
View all 42 locations
View Trial Details
Completed

Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Actinic Keratoses

NCT00107965

Conditions
Actinic Keratosis, Hyperpigmentation, Keratosis, +7 more
Locations
  • Royal Prince Alfred Hospital Sydney, New South Wales, Australia
  • Siller Medical Brisbane, Queensland, Australia
  • Skin and Cancer Foundation Melbourne, Victoria, Australia
  • Monash Medical Centre Melbourne, Victoria, Australia
View Trial Details

Related conditions